Amwell (AMWL) Tops Q2 EPS by 30c
Tweet
Share
E-mail
Get Alerts AMWL Hot Sheet
Join SI Premium – FREE
Amwell (NYSE: AMWL) reported Q2 EPS of ($0.59), $0.30 better than the analyst estimate of ($0.89). Revenue for the quarter came in at $52.05 million versus the consensus estimate of $50.1 million.
For earnings history and earnings-related data on Amwell (AMWL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- eXp World Holdings, Inc. (AGNT) Misses Q2 EPS by 9c; offers guidance
- Spyre Therapeutics, Inc. (SYRE) Tops Q2 EPS by 40c
- OrthoPediatrics (KIDS) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
